COMMUNIQUÉS West-GlobeNewswire

Genetic Technologies Announces Grant from NHMRC Awarded to University of Melbourne to Substantially Improve Breast Cancer Risk Prediction and Increase Accessibility
01/05/2018
MELBOURNE, Australia, May 01, 2018 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX:GTG) (Nasdaq: GENE ) (“Company”), a diversified molecular diagnostics company embracing blockchain technologies across genomic [...]
Trading by management and close relations of management
01/05/2018
Read the full announcement in the attached file Attachment 2018_21_Trading_by_management_EN
Shire plc : Rule 2.9 Announcement
01/05/2018
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION. 1 May 2018 Shire [...]
Motif Bio REVIVE-2 Phase 3 Study Results with Iclaprim Published in Peer-reviewed Journal, Antimicrobial Agents and Chemotherapy
01/05/2018
Iclaprim met the primary endpoint Iclaprim was well tolerated in the study, with no nephrotoxicity observed Additional data from the previously announced results are included in the publication NEW YORK, May 01, 2018 ( [...]
DBV Technologies to Attend Upcoming Investor Conferences
01/05/2018
Montrouge, France, May 1, 2018 DBV Technologies to Attend Upcoming Investor Conferences DBV Technologies (Euronext: DBV - ISIN: FR0010417345 - Nasdaq Stock Market: DBVT), a clinical-stage biopharmaceutical company, [...]
DBV Technologies Invitée à Présenter lors des prochaines Conférences Investisseurs
01/05/2018
Montrouge, France, le 1 mai (7H30 CET), 2018 DBV Technologies Invitée à Présenter lors des prochaines Conférences Investisseurs DBV Technologies (Euronext : DBV - ISIN : FR0010417345 - Nasdaq : DBVT), société [...]
AveXis Provides Update on Proposed Acquisition by Novartis AG
01/05/2018
CHICAGO, May 01, 2018 (GLOBE NEWSWIRE) -- AveXis, Inc. (NASDAQ: AVXS ), a clinical-stage gene therapy company developing treatments for patients suffering from rare and life-threatening neurological genetic diseases, [...]
Novartis provides update on proposed acquisition of AveXis
01/05/2018
Basel, May 1 , 2018 - Novartis AG (NYSE: NVS) ("Novartis") today announced that the required waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976 (the "HSR Act") applicable to Novartis' cash [...]
Medibio Launches Global Corporate Mental Health Product
01/05/2018
Release of first commercially available mental health technology product Notable existing support from key Australian companies Provide organizations with cost savings by reducing mental health burden SYDNEY, Australia [...]
Lexington Releases Audited Consolidated Financial Statements
01/05/2018
VANCOUVER, British Columbia, April 30, 2018 (GLOBE NEWSWIRE) -- Lexington Biosciences, Inc. (CSE:LNB) (OTCQB:LXGTF) (the “Company” or “Lexington”), a development-stage medical device company, has released its audited [...]
MacroGenics Announces Date of First Quarter 2018 Financial Results Conference Call
01/05/2018
ROCKVILLE, MD, April 30, 2018 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (Nasdaq: MGNX) today announced that on Monday, May 7, 2018, the Company will release its financial results for the quarter ended March 31, 2018. The [...]
Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
01/05/2018
CAMBRIDGE, Mass., April 30, 2018 (GLOBE NEWSWIRE) -- Sarepta Therapeutics, Inc. (NASDAQ: SRPT ), a commercial-stage biopharmaceutical company focused on the discovery and development of precision genetic medicine to [...]
Immucor Announces FDA Clearance for Echo Lumena(TM); Next Generation, Fully Automated Instrument Powers Smaller to Mid-Volume Labs
30/04/2018
Faster, clearer blood compatibility results now available NORCROSS, Ga., April 30, 2018 (GLOBE NEWSWIRE) -- Immucor, Inc., a global leader in transfusion and transplantation diagnostics, today announced that its next [...]
Helix BioPharma Corp. Closes Private Placement
30/04/2018
RICHMOND HILL, Ontario, April 30, 2018 (GLOBE NEWSWIRE) -- Helix BioPharma Corp. (TSX: HBP ) (FSE:HBP) (“Helix” or the “Company”), an immuno-oncology company developing innovative drug candidates for the prevention and [...]
Forward Pharma Reports Full-Year 2017 Financial and Operational Results
30/04/2018
COPENHAGEN, Denmark, April 30, 2018 (GLOBE NEWSWIRE) -- Forward Pharma A/S (Nasdaq: FWP ) (“We” or “Forward” or the “Company”), today reported financial results for the year ended December 31, 2017. Net income for the [...]
Flexion Therapeutics to Report First-Quarter 2018 Financial Results on May 8, 2018
30/04/2018
BURLINGTON, Mass., April 30, 2018 (GLOBE NEWSWIRE) -- Flexion Therapeutics, Inc. (Nasdaq: FLXN ) today announced that it will report its first-quarter 2018 financial results after the close of the U.S. financial markets [...]
Portola Pharmaceuticals to Announce First Quarter 2018 Financial Results and Host Conference Call on Wednesday, May 9, 2018
30/04/2018
SOUTH SAN FRANCISCO, Calif., April 30, 2018 (GLOBE NEWSWIRE) -- Portola Pharmaceuticals, Inc. ® (NASDAQ: PTLA ) announced today that it will host a webcast and conference call to discuss the Company’s financial results [...]
Golden Leaf Reports Fiscal Year 2017 Results
30/04/2018
TORONTO, April 30, 2018 (GLOBE NEWSWIRE) -- Golden Leaf Holdings Ltd. (“GLH” or the “Company”) (CSE:GLH) (OTCQB:GLDFF), a leading cannabis oil solutions company built around recognized brands, today announced its [...]
AzurRx BioPharma Announces Proposed Public Offering of Common Stock
30/04/2018
BROOKLYN, N.Y., April 30, 2018 (GLOBE NEWSWIRE) -- AzurRx BioPharma (NASDAQ: AZRX ), (“AzurRx” or the “Company”), announced today that it intends to offer and sell shares of its common stock in an underwritten public [...]

Pages